29.10.2014 Views

Ovacome Summer 2014

Ovacome Summer 2014

Ovacome Summer 2014

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Photography: Daily Echo, Bournemouth<br />

news<br />

Singing to recovery<br />

Gareth Malone, the preppy choirmaster credited with reigniting our interest in<br />

choral singing through his BBC Two series The Choir, would be proud. For word<br />

is getting around about how uplifting being part of a singing group can be and the<br />

benefits are numerous when dealing with illness.<br />

Rising Voices - a community choir for people affected by<br />

cancer in Dorset, Hampshire and Wiltshire - has found in<br />

a study that members have benefited from being part of a<br />

mutually empathetic community, in which they were not<br />

treated as victims.<br />

Altogether Rising Voices: Noëline Young (fourth from left, front row).<br />

As well as getting enjoyment from singing as a group,<br />

members liked the social interaction at weekly rehearsals and<br />

the travel to events, which could be anywhere from a local<br />

shopping centre or Women’s Institute meeting to a twinned<br />

event in Cherbourg.<br />

Concentrated chemo<br />

A<br />

decision on whether to<br />

progress with a new method of<br />

chemotherapy for treating ovarian cancer<br />

could be made soon.<br />

PETROC is a study of the use of<br />

chemotherapy that is given into the<br />

peritoneal space (IP) for ovarian cancer,<br />

rather than into a vein (IV). This<br />

increases the concentration of the drug<br />

around the cancer and can increase its<br />

effectiveness. The study is for patients<br />

who need to complete their treatment<br />

after primary chemotherapy for three<br />

cycles and a successful interval operation.<br />

This technique was new to the UK<br />

while it had been tested previously in<br />

the USA. The early studies had a lot of<br />

problems with toxicity which delayed<br />

acceptance in the UK. However,<br />

medical staff have learnt how to give<br />

the treatment much more safely, and<br />

UK centres have been trained so that<br />

after the first 150 patients there was<br />

no difference in toxicity between the<br />

Carboplatin and Paclitaxel given in the<br />

IP arm or the control IV arm.<br />

There was a third arm in the study using<br />

IP Cisplatin instead of the Carboplatin,<br />

however the independent data<br />

monitoring committee recommended<br />

that this be stopped as it was no more<br />

effective and more toxic.<br />

Member and <strong>Ovacome</strong> trustee Noëline Young says that the<br />

established associations between music and health, both<br />

physical and spiritual, have been well documented and<br />

highlighted in a report by Cardiff University.*<br />

“Participation in music making has been shown to improve<br />

well being and music has the power to communicate with<br />

individuals at times of difficulty. This formed the background<br />

to the establishment of our survivors’ choir, Rising Voices,”<br />

says Noëline, an ovarian cancer survivor herself.<br />

“The intention was to encourage participation in singing<br />

to boost confidence and social interaction and promote<br />

wellbeing, as an aid to recovery from cancer.”<br />

The choir has been supported by a start-up grant from<br />

Macmillan Cancer Support and Dorset Cancer Network, but<br />

longer term it plans to be self-sufficient, supported through<br />

voluntary donations by members, friends, donations and<br />

money raised from public performances.<br />

If you are interested in joining Rising Voices, it rehearses<br />

weekly at St John’s Church in Parkstone, Poole.<br />

e-mail admin@risingvoices.org.uk or phone 07500 676083.<br />

*Gale NS, Enright S, Reagon C, Lewis I, van Deursen R.<br />

A pilot investigation of quality of life and lung function following<br />

choral singing in cancer survivors and their carers. Cancer,<br />

2012; 6:261<br />

The study has now been resubmitted to<br />

Cancer Research UK with the planned<br />

interim analysis to allow the number<br />

of centres giving IP treatment in the<br />

UK to increase from nine to 28 and<br />

to include a further 630 patients in<br />

the trial, to prove whether it increases<br />

survival.<br />

Dr Sean Kehoe, a gynae surgeon.<br />

has reviewed the medical stories on<br />

page 4 and 5<br />

4 Phone <strong>Ovacome</strong>’s nurse led support line on 0845 371 0554 it together

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!